IL2 and breast cancer: Inflammatory cytokines including interleukins (IL-1β, IL-2, IL-6, IL-8, IL-12), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) are key inflammatory mediators of interest in breast cancer progression.